Nantilus
Cancer biotherapy & radiopharmaceuticals
Enregistré dans:
| Format : | Revue |
|---|---|
| Langue : | anglais |
| Titre complet : | Cancer biotherapy & radiopharmaceuticals |
| Publié : |
Larchmont, NY :
Mary Ann Liebert
, 1996- |
| Documents associés : | Fusion de:
Cancer biotherapy Fusion de: Antibody immunoconjugates, and radiopharmaceuticals Autre format: Cancer biotherapy & radiopharmaceuticals (Online) |
| LEADER | 01494cas a2200445 4500 | ||
|---|---|---|---|
| 001 | PPN037409344 | ||
| 003 | http://www.sudoc.fr/037409344 | ||
| 005 | 20141016033200.0 | ||
| 011 | |a 1084-9785 |f 1084-9785 | ||
| 035 | |a (OCoLC)33232704 | ||
| 035 | |a ccn1084-9785 | ||
| 035 | |a ccn7137/1389 | ||
| 035 | |z ccn7137/1389 | ||
| 035 | |a issn10849785 | ||
| 040 | |a CBRAFJ | ||
| 100 | |a 19960419a19969999k y0frey0103 ba | ||
| 101 | 0 | |a eng | |
| 102 | |a US | ||
| 105 | |a y ||||||||| | ||
| 106 | |a r | ||
| 110 | |a aga|||||||| | ||
| 200 | 1 | |a Cancer biotherapy & radiopharmaceuticals |b Texte imprimé | |
| 207 | 0 | |a Vol. 11, n1̊ (1996, fév.)-... | |
| 210 | |a Larchmont, NY |c Mary Ann Liebert |d 1996- | ||
| 436 | | | |0 038042061 |t Cancer biotherapy |x 1062-8401 | |
| 436 | | | |0 037826433 |t Antibody immunoconjugates, and radiopharmaceuticals |x 0892-7049 | |
| 452 | | | |0 104870818 |t Cancer biotherapy & radiopharmaceuticals (Online) |x 1557-8852 | |
| 517 | | | |a Cancer biotherapy and radiopharmaceuticals | |
| 530 | 0 | |a Cancer biotherapy & radiopharmaceuticals | |
| 531 | |a Cancer biother. radiopharm. | ||
| 675 | |a 616 | ||
| 676 | |a 615 | ||
| 801 | 3 | |a FR |b Abes |c 20110301 |g AFNOR | |
| 801 | 3 | |a FR |b ISSN |c 20051021 | |
| 802 | |a 01 | ||
| 930 | |5 441092101:117418722 |b 441092101 |l 244629 |a QZ 200 - P5037 |j f | ||
| 937 | |a BU Santé |c : vol. 11 (1996) - vol. 16 (2001) |f Cote : QZ 200 - P5037 | ||
| 955 | 4 | 1 | |5 441092101:117418722 |a 11 |i 1996 |a 16 |i 2001 |r vol. 11 (1996) - vol. 16 (2001) |
| 979 | |a SAN | ||
| 998 | |a 369571 | ||